Jonathan E. Lim - 15 Jul 2021 Form 3 Insider Report for Erasca, Inc. (ERAS)

Role
Chairman and CEO Exhibit List: 24 - Power of Attorney, Director, 10%+ Owner
Signature
/s/ Ebun S. Garner, Attorney-in-fact
Issuer symbol
ERAS
Transactions as of
15 Jul 2021
Transactions value $
$0
Form type
3
Filing time
15 Jul 2021, 21:32:06 UTC
Next filing
20 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ERAS Common Stock 15M 15 Jul 2021 By Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005 F1, F2
holding ERAS Common Stock 6.46M 15 Jul 2021 By City Hill, LLC F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ERAS Series A Preferred Stock 15 Jul 2021 Common Stock 5.14M $0.00 By the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005 F2, F4
holding ERAS Series A Preferred Stock 15 Jul 2021 Common Stock 5.07M $0.00 By City Hill, LLC F3, F4
holding ERAS Series B-1 Preferred Stock 15 Jul 2021 Common Stock 280K $0.00 By City Hill, LLC F3, F5
holding ERAS Series B-2 Preferred Stock 15 Jul 2021 Common Stock 93.3K $0.00 By City Hill, LLC F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,644,532 shares subject to repurchase by us, which are subject to vesting.
F2 The securities reported herein may be deemed beneficially owned by each of (i) Jonathan E. Lim, M.D. and (ii) Conyee T. Lim, M.D., who are co-trustees of the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005.
F3 Consists of shares held directly by City Hill, LLC ("City Hill"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of such securities. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein.
F4 The shares of Series A Preferred Stock are convertible, at any time, at the holder's election, to shares of the Issuer's common stock at a ratio of 1.2-for-1. In addition, effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of Series A Preferred Stock will automatically convert to shares of the Issuer's common stock at a ratio of 1.2-for-1. The Series A Preferred Stock has no expiration date.
F5 The shares of Series B Preferred Stock are convertible, at any time, at the holder's election, to shares of the Issuer's common stock at a ratio of 1.2-for-1. In addition, effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of Series B Preferred Stock will automatically convert to shares of the Issuer's common stock at a ratio of 1.2-for-1. The Series B Preferred Stock has no expiration date.

Remarks:

Chairman and CEO Exhibit List: 24 - Power of Attorney